101 related articles for article (PubMed ID: 22980664)
1. [Expression of MCP-1 in the patients of chronic hepatitis B complicated with nonalcoholic fatty liver disease].
Shen HY; Deng YC; Wang QM; Li QS; Xu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Sep; 28(9):975-8. PubMed ID: 22980664
[TBL] [Abstract][Full Text] [Related]
2. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
3. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and identification of non-alcoholic fatty liver disease in chronic hepatitis B virus infected mice].
Zhang Z; Pan Q; Duan XY; Shi JP; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):658-63. PubMed ID: 22152379
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.
Ding WJ; Wang MM; Wang GS; Shen F; Qin JJ; Fan JG
J Gastroenterol Hepatol; 2015 Dec; 30(12):1753-8. PubMed ID: 25974331
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China.
Li X; Ren N; Ling W; Chen F; Zhang W; Fan X; Tian M; Zhang T; Li B; Pfeffer LM; Wu H; Zhang J
Hepatogastroenterology; 2012 Sep; 59(118):1735-43. PubMed ID: 22819899
[TBL] [Abstract][Full Text] [Related]
7. The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease.
Liang J; Cai W; Han T; Jing L; Ma Z; Gao Y
Medicine (Baltimore); 2016 Dec; 95(52):e5763. PubMed ID: 28033294
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
Haukeland JW; Damås JK; Konopski Z; Løberg EM; Haaland T; Goverud I; Torjesen PA; Birkeland K; Bjøro K; Aukrust P
J Hepatol; 2006 Jun; 44(6):1167-74. PubMed ID: 16618517
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease.
Mendez-Sanchez N; Zamora-Valdes D; Pichardo-Bahena R; Barredo-Prieto B; Ponciano-Rodriguez G; Bermejo-Martínez L; Chavez-Tapia NC; Baptista-González HA; Uribe M
Liver Int; 2007 Mar; 27(2):215-9. PubMed ID: 17311616
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
[TBL] [Abstract][Full Text] [Related]
11. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
[TBL] [Abstract][Full Text] [Related]
12. Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation.
Kirovski G; Dorn C; Huber H; Moleda L; Niessen C; Wobser H; Schacherer D; Buechler C; Wiest R; Hellerbrand C
Exp Mol Pathol; 2011 Dec; 91(3):780-3. PubMed ID: 21855538
[TBL] [Abstract][Full Text] [Related]
13. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
14. Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure.
Qi ZX; Wang LY; Fan YC; Zhang JJ; Li T; Wang K
J Viral Hepat; 2012 Nov; 19(11):811-22. PubMed ID: 23043388
[TBL] [Abstract][Full Text] [Related]
15. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
Peng D; Han Y; Ding H; Wei L
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
Rüzgar M; Cetin Akhan S; Vahaboğlu H
Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426
[TBL] [Abstract][Full Text] [Related]
18. Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B.
Yang RX; Hu CX; Sun WL; Pan Q; Shen F; Yang Z; Su Q; Xu GW; Fan JG
Sci Rep; 2017 Sep; 7(1):10517. PubMed ID: 28874844
[TBL] [Abstract][Full Text] [Related]
19. Depression and anxiety in nonalcoholic steatohepatitis: is there any association?
Surdea-Blaga T; Dumitraşcu DL
Rom J Intern Med; 2011; 49(4):273-80. PubMed ID: 22568272
[TBL] [Abstract][Full Text] [Related]
20. Increased interleukin-32 expression in chronic hepatitis B virus-infected liver.
Xu Q; Pan X; Shu X; Cao H; Li X; Zhang K; Lu J; Zou Y; Li X; Liu H; Zhang Y; Yang D; Ning Q; Shen G; Li G
J Infect; 2012 Oct; 65(4):336-42. PubMed ID: 22687868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
